Anderson inks partnership powered by AI cancer diagnostics to develop genomic tools that improve cancer diagnosis and treatment decisions.

Veracyte, Inc., a leading cancer diagnostics company, today announced that data from its market-leading Decipher Prostate Genomic Classifier are available in a new specialized database that the ...

The two companies will explore how datma's federated ecosystem can support Rhythm Biosciences' diagnostic development efforts as they shape a future commercial agreement. As genomic-integrated ...

The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...

From the earliest days of the pandemic that shocked the world in 2020, researchers at Fred Hutch Cancer Center tracked the rapid evolution and spread of the virus that causes COVID-19 by studying how ...

According to MarketsandMarkets, the Genomic Biomarkers Market is projected to grow from about USD 29.00 billion in 2025 to USD 50.31 billion ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from its market-leading Decipher Prostate Genomic ...